SCHEMBL11113912

SCHEMBL11113912

CCN(CC)CCCC1c2c(c3ccccc3n2C)CCN1C(C)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 2/20 0.41
▸ ABCB1 P08183 1/20 0.40
▸ ABCG2 Q9UNQ0 1/20 0.40
▸ KDM4E B2RXH2 10/20 0.40
▸ ALDH1A1 P00352 8/20 0.39
▸ HSD17B10 Q99714 6/20 0.39
▸ SLC6A4 P31645 3/20 0.38
▸ SLC6A2 P23975 1/20 0.38
▸ HRH1 P35367 1/20 0.38
▸ TSHR P16473 5/20 0.38
▸ MTNR1B P49286 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ HPGD P15428 5/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ GLA P06280 2/20 0.35
▸ GAA P10253 2/20 0.35
▸ TP53 P04637 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10804503 0.93 ABCB1 (0.40) EGFRABCB1ABCG2KDM4EALDH1A1
SCHEMBL10854756 0.93 ABCB1 (0.40) ABCB1ABCG2KDM4EALDH1A1HSD17B10
SCHEMBL10816796 0.90 ABCB1 (0.39) EGFRABCB1ABCG2KDM4EALDH1A1
SCHEMBL10851137 0.90 HTR5A (0.40) EGFRABCB1ABCG2KDM4EALDH1A1
SCHEMBL10808165 0.89 TP53 (0.39) ABCB1ABCG2KDM4ESLC6A4MTNR1B
SCHEMBL10804195 0.87 ABCB1 (0.38) ABCB1ABCG2KDM4ESLC6A4MTNR1B
SCHEMBL10859924 0.87 ABCB1 (0.38) ABCB1ABCG2KDM4EALDH1A1HSD17B10
SCHEMBL11112201 0.87 HTR5A (0.39) EGFRABCB1ABCG2KDM4ESLC6A4
SCHEMBL10857236 0.86 ABCB1 (0.38) ABCB1ABCG2KDM4EALDH1A1SLC6A4
SCHEMBL11105995 0.86 TP53 (0.39) ABCB1ABCG2KDM4ESLC6A4MTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0101574-A1 2-Substituted 1-aminoalkyl-1,2,3,4-tetrahydro-beta-carbolines, their preparation and use as medicaments BASF Aktiengesellschaft (DE) 1984-02-29 — — EP disclosed
Send feedback